Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05502510 · ClinicalTrials.gov registry record
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
A clinical trial of Pregnancy Related and Preterm Birth, sponsored by Naima Health.
- Completed
- Registry status
- 12,344
- Enrollment target
- 1
- Study location
NCT05502510: Completed study of Pregnancy Related and Preterm Birth, sponsored by Naima Health.
NCT05502510 is a study of Pregnancy Related and Preterm Birth that has completed, run by Naima Health. The registered enrollment target is 12,344 participants, above the 1,838-participant average among 99 other Pregnancy Related trials with a reported enrollment target (572% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05502510, a study of Pregnancy Related and Preterm Birth, has completed, sponsored by Naima Health.
- COMPLETED
- Registry status
- 12,344 participants
- Enrollment target
- 1
- Study location
Study Summary
One in ten births will occur prior to 37 weeks of gestation leading to serious complications such as problems with lung, heart and brain function and an increased risk of infant mortality. Solutions exist to treat risk factors related to preterm birth but these solutions require timely identification of the risks which is often not possible within regular prenatal care. This study will evaluate MyHealthyPregnancy, an application that monitors for common risks associated with preterm birth and recommends solutions to the expectant mother and care team.
Primary Outcome
Gestational age at birth will be measured using each patients electronic health record. The average treatment effect will be calculated using linear regression comparing MHP and usual care cohorts. Efficacy of the application will be assessed using a dose-response model to evaluate how use of the application affects gestational age at birth.
Conditions Studied
Interventions
- BEHAVIORAL MyHealthyPregnancy
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,344 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2022-02-28 |
What the finished NCT05502510 record still lists
NCT05502510 is an observational study that tracks outcomes without assigning an intervention. Its 12,344 participants enrollment target places it among the larger protocols in the corpus, above the 1,838-participant average among 99 other Pregnancy Related trials with a reported enrollment target (572% higher).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which MyHealthyPregnancy is the first listed.
NCT05502510 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05502510 about?
NCT05502510 is a clinical study titled "Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application". One in ten births will occur prior to 37 weeks of gestation leading to serious complications such as problems with lung, heart and brain function and an increased risk of infant mortality. Solutions exist to treat risk factors related to preterm birth but these solutions require timely identificatio...
What is the current status of trial NCT05502510?
This trial is currently completed. The enrollment target is 12,344 participants. The study started on 2019-09-23. Estimated completion is 2022-02-28.
What conditions does trial NCT05502510 study?
This clinical trial studies the following conditions: Pregnancy Related, Preterm Birth.
What interventions are being tested in trial NCT05502510?
The interventions under investigation include: MyHealthyPregnancy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05502510?
This trial is sponsored by Naima Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05502510 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05502510's enrollment target sits among peer trials
12,344 3rd of 99 higher than 97 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI